The Leiden Bio Science Park is proud to announce the partnership with 360Pharma, supported by the Career Lab initiative, to launch an advanced talent portal connecting companies and jobseekers. With a first test session already behind us we’re well on our way…
-
-
The project is focused on improving gene editing and gene therapy manufacturing, strengthening Europe’s position in these areas.
-
The Stichting LBSP (Leiden Bio Science Park Foundation) is proud to announce the partnership with 360Pharma, supported by the Career Lab initiative, to launch an advanced talent portal on the 16th March 2025.
-
Leiden, Netherlands – January 28, 2025 – MIMETAS, a leader in human disease modeling, has launched OrganoPlate UniFlow (UF), the first commercially available unidirectional, gravity-driven pumpless flow system for drug discovery and disease research. The platform debuts at SLAS 2025,…
-
Leiden, 22 January 2025 – Toxys has been awarded £1 million in funding for phase 2 of the CrossDART CRACK IT Challenge, following the successful completion of phase 1. This initiative focuses on developing reliable cell-based in vitro assays that…
-
Leiden Bio Science Park Director Esther Peters joined Gerry van Bakel on Sleutelstad ‘s Kennismakers to discuss the park’s role in shaping The Future of Health. The conversation dove into boosting growth in one of Europe’s most dynamic life sciences…
-
Pharming Group has nominated Fabrice Chouraqui as the successor to CEO Sijmen de Vries. His appointment will be subject to approval at an Extraordinary General Meeting of Shareholders (EGM). Upon his appointment, Chouraqui will join the Board of Directors, while…
-
Toxys and Unilever have joined forces to advance New Approach Methodologies (NAMs) for assessing cellular stress—an essential factor in Next Generation Risk Assessment (NGRA). This collaboration aims to refine non-animal testing approaches by validating ToxProfiler, Toxys’ advanced assay, and expanding…
-
Leyden Labs, based at Leiden Bio Science Park, has raised $70 million to develop a new way to fight respiratory viruses.